CINF
31
2
FLR
52
4
DOW
36
-2
MCK
52
-3
ROST
66
-2
CCL
72
2
PRU
47
-4
CME
56
-3
A
41
-3
RHI
59
2
SYF
86
3
WY
48
-2
URBN
70
-2
DFS
71
4
HRL
50
-3
AVB
57
2
FIS
50
4
NI
67
2
PFG
33
-3
WYNN
32
2
CINF
31
2
FLR
52
4
DOW
36
-2
MCK
52
-3
ROST
66
-2
CCL
72
2
PRU
47
-4
CME
56
-3
A
41
-3
RHI
59
2
SYF
86
3
WY
48
-2
URBN
70
-2
DFS
71
4
HRL
50
-3
AVB
57
2
FIS
50
4
NI
67
2
PFG
33
-3
WYNN
32
2
Financhill
Back

Replimune Group Stock Predictions

Better Than Oil Stocks

CLICK HERE TO FIND OUT MORE
Sell
29

REPL
Replimune Group

Last Price:
12.65
Seasonality Move:
-15.42%

7 Day Trial

ALL ACCESS PASS

$ 7

Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!

Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)

Replimune Group Stock Forecast

  • Over the next 52 weeks, Replimune Group has on average historically risen by 25.4% based on the past 6 years of stock performance.
  • Replimune Group has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Replimune Group Stock Undervalued?
    The current Replimune Group [REPL] share price is $12.64. The Score for REPL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Replimune Group Stock Go Up Next Year?

  • Over the next 52 weeks, Replimune Group has on average historically risen by 25.4% based on the past 6 years of stock performance.

Replimune Group Stock Rating

Sell
29
Replimune Group (REPL) is a Sell

Is Replimune Group overpriced?

  • Replimune Group has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Replimune Group Stock Price History

Is REPL stock going to rise?

  • The current trend is moderately bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
replimune.com

52-Week Data

52-Week High:
17.00
52-Week Low:
4.92

Prediction Charts

Market Cap:
864.8M
Price in USD:
12.64
Volume:
624.02K
Beta:
1.58

Technical Analysis

SMA50:
12.14
SMA100:
11.24
SMA200:
9.46
52-Wk Change:
69.66%

Stock Predictions

  • Is Replimune Group stock public?
    Yes, Replimune Group is a publicly traded company.
  • What is the Replimune Group stock quote today?
    The Replimune Group stock price is 12.64 USD today.
  • How to buy Replimune Group stock online?
    You can buy Replimune Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-21 11.14 11.05 11.35 11.00
Nov-22 13.68 14.93 17.00 13.13
Nov-25 15.12 13.26 15.12 12.71
Nov-26 13.64 14.38 14.57 13.20
Nov-27 14.38 14.05 14.64 13.79
Nov-29 14.06 14.08 14.51 14.00
Dec-2 14.00 13.55 14.22 13.47
Dec-3 13.49 13.14 13.60 12.92
Dec-4 13.40 13.17 13.68 13.08
Dec-5 13.19 13.05 13.34 12.96
Dec-6 13.11 13.08 13.22 12.93
Dec-9 13.18 12.64 13.38 12.61
Dec-10 12.47 12.84 12.89 12.14
Dec-11 12.83 12.64 13.13 12.54

Replimune Group Earnings

Replimune Group Earnings Report: Per Share Replimune Group Earnings Q1 Q2 Q3 and Q4 last year and next year.

Replimune Group Forecast Revenue Growth

Replimune Group Stock Analysis: Historical quarterly revenues per share for Replimune Group and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.

* Replimune Group stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.